-
Signature
-
/s/Carolyn Rucci, attorney-in-fact for Richard C. Malabre
-
Issuer symbol
-
AKBA
-
Transactions as of
-
04 Jun 2025
-
Net transactions value
-
-$47,069
-
Form type
-
4
-
Filing time
-
05 Jun 2025, 16:35:02 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Malabre Richard C |
SVP, Chief Accounting Officer |
C/O AKEBIA THERAPEUTICS, INC, 245 FIRST ST., CAMBRIDGE |
/s/Carolyn Rucci, attorney-in-fact for Richard C. Malabre |
05 Jun 2025 |
0002007730 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AKBA |
Common Stock |
Sale |
$47,069 |
-13,334 |
-4.8% |
$3.53 |
266,914 |
04 Jun 2025 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: